Tyler Lipschultz - Jan 5, 2023 Form 4 Insider Report for SeaSpine Holdings Corp (SPNE)

Signature
/s/Paul Benny, Attorney-in-Fact for Tyler Lipschultz
Stock symbol
SPNE
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 06:18 PM
Previous filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPNE Common Stock Disposed to Issuer -131K -100% 0 Jan 5, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPNE Restricted Stock Units Disposed to Issuer -13K -100% 0 Jan 5, 2023 Common Stock 13K Direct F2, F3, F4
transaction SPNE Restricted Stock Units Disposed to Issuer -34K -100% 0 Jan 5, 2023 Common Stock 34K $0.00 Direct F2, F5, F6
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -60K -100% 0 Jan 5, 2023 Common Stock 60K $15.68 Direct F7, F8
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -64.6K -100% 0 Jan 5, 2023 Common Stock 64.6K $14.19 Direct F9, F10
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -35.6K -100% 0 Jan 5, 2023 Common Stock 35.6K $18.24 Direct F11, F12
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -27.9K -100% 0 Jan 5, 2023 Common Stock 27.9K $12.01 Direct F13, F14
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -6.09K -100% 0 Jan 5, 2023 Common Stock 6.09K $9.93 Direct F15, F16
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -16.2K -100% 0 Jan 5, 2023 Common Stock 16.2K $16.86 Direct F17, F18
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -21.2K -100% 0 Jan 5, 2023 Common Stock 21.2K $15.00 Direct F19, F20
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Tyler Lipschultz is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 54,653 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
F4 These restricted stock units were assumed by Orthofix in the merger and replaced by 5,399 Orthofix restricted stock units.
F5 The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
F6 These restricted stock units were assumed by Orthofix in the merger and replaced by 14,144 Orthofix restricted stock units.
F7 The option vests as to 25% of the underlying shares on August 1, 2016 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter.
F8 This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,978 shares of Orthofix at a price of $37.67 per share.
F9 The option vests as to 12.5% of the underlying shares on August 1, 2016, 6.25% on September 30, 2016 and the remaining 81.25% vests in thirteen substantially equal quarterly installments thereafter.
F10 This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share.
F11 The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F12 This option was assumed by Orthofix in the merger and replaced with an option to purchase 14,835 shares of Orthofix at a price of $43.82 per share.
F13 The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F14 This option was assumed by Orthofix in the merger and replaced with an option to purchase 11,603 shares of Orthofix at a price of $28.85 per share.
F15 The option fully vested and became exercisable on June 21, 2020.
F16 This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share.
F17 The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F18 This option was assumed by Orthofix in the merger and replaced with an option to purchase 6,742 shares of Orthofix at a price of $40.50 per share.
F19 The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F20 This option was assumed by Orthofix in the merger and replaced with an option to purchase 8,840 shares of Orthofix at a price of $36.04 per share.